AbbVie Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AbbVie Inc. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Option Exercise | A | 93.50 | 24,549 | 2,295,332 | 24,549 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,899 | 0 | 15,035 | 13.1 K to 15 K (+14.46 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 574 | 0 | 13,136 | 12.6 K to 13.1 K (+4.57 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,075 | 0 | 12,562 | 11.5 K to 12.6 K (+9.36 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 2,979 | 0 | 11,487 | 8.5 K to 11.5 K (+35.01 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 93.50 | 229,132 | 21,423,842 | 229,132 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 3,675 | 0 | 523,561 | 527.2 K to 523.6 K (-0.70 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 29,107 | 0 | 527,236 | 498.1 K to 527.2 K (+5.84 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 23,604 | 0 | 498,129 | 474.5 K to 498.1 K (+4.97 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 39,109 | 0 | 474,525 | 435.4 K to 474.5 K (+8.98 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 108,442 | 0 | 435,416 | 327 K to 435.4 K (+33.17 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 93.50 | 114,566 | 10,711,921 | 114,566 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 10,125 | 0 | 200,316 | 190.2 K to 200.3 K (+5.32 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,214 | 0 | 190,191 | 182 K to 190.2 K (+4.51 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 181,977 | 167.6 K to 182 K (+8.55 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 39,760 | 0 | 167,637 | 127.9 K to 167.6 K (+31.09 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Option Exercise | A | 93.50 | 72,013 | 6,733,216 | 72,013 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Grant | A | 0.00 | 5,316 | 0 | 17,504 | 12.2 K to 17.5 K (+43.62 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 93.50 | 96,563 | 9,028,641 | 96,563 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 7,972 | 0 | 104,544 | 96.6 K to 104.5 K (+8.25 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 96,572 | 90 K to 96.6 K (+7.28 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 90,017 | 78.3 K to 90 K (+14.98 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 32,524 | 0 | 78,287 | 45.8 K to 78.3 K (+71.07 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Option Exercise | A | 93.50 | 62,193 | 5,815,046 | 62,193 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 2,532 | 0 | 25,120 | 22.6 K to 25.1 K (+11.21 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 1,239 | 0 | 22,588 | 21.3 K to 22.6 K (+5.80 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 2,280 | 0 | 21,349 | 19.1 K to 21.3 K (+11.96 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 6,321 | 0 | 19,069 | 12.7 K to 19.1 K (+49.58 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Option Exercise | A | 93.50 | 106,382 | 9,946,717 | 106,382 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 8,859 | 0 | 27,708 | 18.8 K to 27.7 K (+47.00 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 1,485 | 0 | 18,849 | 17.4 K to 18.8 K (+8.55 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 1,710 | 0 | 17,364 | 15.7 K to 17.4 K (+10.92 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 4,741 | 0 | 15,654 | 10.9 K to 15.7 K (+43.44 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Option Exercise | A | 93.50 | 78,559 | 7,345,267 | 78,559 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,999 | 0 | 34,907 | 29.9 K to 34.9 K (+16.71 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,104 | 0 | 29,908 | 25.8 K to 29.9 K (+15.90 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 6,840 | 0 | 25,804 | 19 K to 25.8 K (+36.07 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 18,964 | 0 | 18,964 | 0 to 19 K |